SRSusan L. Rosenthal

Susan L. Rosenthal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Susan L. Rosenthal has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mental health and cognition in relation to adherence to antiretroviral therapy among people living with HIV in Kazakhstan: a cross‐sectional study

    by Gaukhar Mergenova, Alissa Davis, Louisa Gilbert, Nabila El‐Bassel, Assel Terlikbayeva, Sholpan Primbetova, Zhamilya Nugmanova, Andrea Norcini Pala, Deborah Gustafson, Susan L. Rosenthal, et al.

    Introduction: There is a research gap in how mental health and cognition are associated with antiretroviral treatment (ART) adherence among people living with HIV (PLWH) in Kazakhstan.Methods: We randomly selected and enrolled 230 PLWH from the Almaty City AIDS Center registry (June−November 2019) into a cross‐sectional study. We examined associations between self‐reported ART adherence for the last 1 and 2 weeks; the Adherence Self‐Efficacy Scale (ASES) and symptoms of depression (Patient Health Questionnaire‐9 [PHQ‐9]), anxiety (Generalized Anxiety Disorder tool [GAD‐7]), post‐traumatic stress disorder (PTSD Checklist [PTSD]); cognitive function (PROMIS v2.0 Adult Cognitive Function 8a short form) and forgetfulness (Forgetfulness Assessment Inventory). We used cut points of ≥5 for at least mild and ≥10 for at least moderate symptom severity for PHQ‐9 and GAD‐7 and of ≥44 for PTSD. Logistic and linear regression analyses were used.Results: Participants’ median age was 40.0 (IQR: 34−47) with 40.9% (n = 94) of females in the sample. Those who missed at least one pill for the last 2 weeks had higher odds of reporting at least mild depression (aOR = 3.34, 95% CI: 1.22–9.11, p < 0.05); mild anxiety (aOR = 3.27, 95% CI: 1.20–8.92, p < 0.05); and PTSD (aOR = 4.04, 95% CI: 1.15–14.21, p < 0.05) symptoms. Participants who missed at least one pill for the last week had higher odds of at least mild depression (aOR = 7.74, 95% CI: 1.31–45.7, p < 0.05), moderate anxiety (aOR = 21.33, 95% CI: 3.24–140.33, p < 0.005) and PTSD (aOR = 13.81, 95% CI: 2.36–80.84, p < 0.005) symptoms. Participants with better cognitive function had lower odds of non‐adherence over the last week (aOR = 0.88, 95% CI: 0.81–0.96, p < 0.005) and higher ASES scores (β = 0.26, 95% CI: 0.13–0.40, p < 0.005). Poor memory was associated with higher odds of non‐adherence over the last week (aOR = 4.64, 95% CI: 1.76–12.24, p < 0.005) and lower ASES score (β = −0.31, 95% CI: −0.45 to 0.16, p < 0.005). Those who had at least mild depression (β = −0.21, 95% CI: −0.35 to −0.07, p < 0.005); moderate anxiety (β = −0.21, 95% CI: −0.34 to −0.07, p < 0.005) and PTSD (β = −0.19, 95% CI: −0.33 to −0.05, p < 0.005) symptoms had lower ASES scores.Conclusions: Depression, anxiety and PTSD symptoms, poorer cognition, and forgetfulness were associated with poorer ART adherence and worse adherence self‐efficacy. It is crucial to assess and treat mental illness and provide support for PLWH with worsened cognition to enhance ART adherence.


  • Open Access

    Infection prevention and control and related practices in African neonatal units: The Pan-African neonatal care assessment study (PANCAS)

    by Irene Frantzis, Stéphanie Levasseur, Jack Huebner, Maitry Mahida, Philip Larussa, Wilmot James, Workeabeba Abebe, Crispen Ngwenya, Ezekiel Mupere, Susan L. Rosenthal, et al.


  • Provider and staff crisis well‐being associated with trust in leadership and baseline burnout

    by Scott Moerdler, Dara M. Steinberg, Zhezhen Jin, Peter D. Cole, Jennifer Kesselheim, Adam S. Levy, Michael Roth, Susan L. Rosenthal

    Background: The impact of the coronavirus 2019 (COVID‐19) pandemic on the emotional health of health care workers continues to be an area of active research. However, few studies have focused on those working in pediatrics and its subspecialties, as well as ancillary and non‐patient‐facing staff. The purpose of this study was to determine the prevalence and associated predictors of burnout and emotional well‐being of providers and staff.Methods: An anonymous electronic survey was developed evaluating demographics, pandemic experiences, possible predictor variables, and three main outcomes of burnout, psychological distress, and perceived stress. Pediatric hematology oncology (PHO) chiefs and program directors across the country were invited to participate and disseminate the survey to their programs.Results: A total of 682/1950 (35% of invited) individuals responded to all predictor and outcome variables. Over half reported high levels of burnout and some reported moderate/high levels of distress. Prepandemic burnout and decreased trust in leadership were associated with all three outcomes. Additional predictors included having a child ≤18 years at home, hospital role, and worrying about patient care or relationship with their patients. The majority (n = 444/682, 65.5%) reported that their institution had made COVID‐19‐related mental health resources available. However, only 6.5% (n = 44/682) reported utilizing these resources.Conclusions: While the majority of PHO providers and staff were resilient during the early stages of the COVID‐19 pandemic, many reported high levels of burnout, yet few are utilizing institutional resources. This study has highlighted several actionable areas to help identify and address factors that are wearing down the emotional well‐being of providers and staff.


  • Open Access

    Adolescent and Parent Perceptions about Participation in Biomedical Sexual Health Trials

    by Sara E. Landers, Jenny K. R. Francis, Marilyn C. Morris, Christine Mauro, Susan L. Rosenthal

    Given the burden of HIV and other sexually transmitted infections among adolescents who are legal minors, it is critical that they be included in biomedical sexual health trials to ensure that new prevention and treatment interventions are safe, effective, and acceptable for their use. However, adolescents are often not well represented in clinical trials. We provide an overview of the available evidence regarding adolescent and parent willingness for adolescents to participate in biomedical sexual health trials, parental involvement in the permission‐consent process, management of differences and discord among adolescents and parents, and parental involvement throughout the study period. We also outline recommendations for current practice and areas for future research.


  • Acceptability of a Phone App-Based Motivational Interviewing Intervention for Young Men’s Health

    by Alexis Guzman, Sara E. Landers, Meredith Nechitilo, Samantha Garbers, Marina Catallozzi, Melanie A. Gold, David L. Bell, Susan L. Rosenthal


  • Open Access

    Adolescents’ and Parents’ Attitudes Toward Adolescent Clinical Trial Participation: Changes Over One Year

    by Rebecca K. Tsevat, Carmen Radecki Breitkopf, Sara E. Landers, Ariel M. de Roche, Christine Mauro, Lisa S. Ipp, Marina Catallozzi, Susan L. Rosenthal

    Little is known about how adolescents’ and parents’ thoughts about participation in clinical trials change over time. In this study, adolescent (14-17 years)–parent dyads were asked about willingness to participate in a hypothetical reproductive health study. A year later, they were asked how their thoughts about the study had changed. Qualitative responses were coded and analyzed using framework analysis. Thirty-two percent of adolescents and 18% of parents reported changes in thoughts; reasons included general changes in perception, clearer understanding, new knowledge or experiences, increased maturity/age of adolescents, and changes in participants independent of the study. Adolescents and parents may benefit from learning about studies multiple times, and investigators should account for development and new experiences to optimize adolescent research enrollment.


  • Pregnant young women’s attitudes about microbicides: the anticipated influence of the grandmother and father of the baby on microbicide use

    by Jenny K. R. Francis, Lauren Dapena Fraiz, Marina Catallozzi, Ariel M. Deroche, Christine Mauro, Susan L. Rosenthal

    Grandmothers and fathers of the baby may influence pregnant women’s microbicide use. Pregnant young women’s attitudes about grandmothers’ and fathers’ role in decision-making and their involvement in microbicide use were assessed. Participants (n = 108) had a mean age of 20.2 years. The majority anticipated that the grandmother, father or both would have a decision-making role. Greater grandmother involvement in microbicide use was significantly associated with being younger, having no reproductive tract infection or contraceptive-ring-use history. Greater father involvement in use was associated with being in a relationship with him. Strategies for engaging grandmothers and fathers in microbicide use should be developed.


  • Open Access

    P4.146 Disclosing Genital Herpes: Perceptions of Motivation, Logistics and Timing

    by M Catallozzi, S C Ebel, N R Chavéz, L Shearer, A Mindel, S L Rosenthal

    Objective The aim of the study was to evaluate the lay public’s portrayal of disclosure of Herpes simplex virus (HSV) infection. Methods The Australian Herpes Management Forum and Novartis Pharmaceuticals organised an on-line contest in 2011, challenging contestants to develop 30-second videos addressing ‘how you tell a partner you have HSV’ given that ‘for many people shame and stigma are so overwhelming that they don’t feel comfortable talking about it.’ Results Sixty-three videos were analysed for the following thematic content regarding disclosure: motivation, strategies/logistics and timing/context. The portrayed motivations included: no reason not to disclose, given the ease of disease management; to be consistent with values (e.g., respect, honesty); or to avoid the risk of accidental ‘outing’. Other videos only commanded disclosure without providing a rationale. With regards to strategies and logistics, most disclosures occurred in a private or semi-private setting, often of a romantic/intimate nature and in a direct manner. However, some used an indirect/non-verbal approach (e.g., giving a pamphlet or as part of a game). A few showed consideration of the partner’s need for time to respond. A few showed the individual practising disclosure. The timing and context of disclosure varied and was often unclear; however, some videos demonstrated disclosure occurring post-coitally. Conclusions Some video creators viewed disclosure as occurring in romantic settings, post-coitally, and in a non-direct manner, all of which are not consistent with traditional counselling messages. Disclosing in a romantic setting and in non-direct ways may be reasonable; it would still be desirable for disclosure to occur pre-coitally. Understanding these differences may help develop counselling messages that resonate with patient expectations and are more effective in promoting disclosure. Future research should collect patient experiences and perceived outcomes of disclosure in terms of the setting, method, and timing of disclosure.

  • 32: Vaccine-Type HPV Infection and Post-Licensure Attitudes About HPV Vaccination in Young Women

    by Jessica A. Kahn, Susan L. Rosenthal, Yan Jin, Bin Huang, Azadeh Namakydoust, Jennifer Rosemore, Erin Medlin, Gregory D. Zimet


  • Open Access

    Young men's views about topical microbicides

    by S. L. Rosenthal, S. S. Cohen, M. Gevelber, L. R. Stanberry